0
ARTICLE |

RELATION OF RELAPSES IN TYPHOID TO DURATION OF CHLORAMPHENICOL THERAPY

JOSEPH E. SMADEL, M.D.; THEODORE E. WOODWARD, M.D.; CHARLES A. BAILEY, M.D.
JAMA. 1949;141(2):129. doi:10.1001/jama.1949.62910020002006b.
Text Size: A A A
Published online

During the past year much information has accumulated on the use of chloramphenicol (chloromycetin®) in the treatment of typhoid. This confirms the original report of Woodward and others,1 covering the observations on 10 patients, which clearly indicated that the new antibiotic was of great value in this disease. Continued experience reveals that fever disappears by lysis during the first three or four days of treatment.

Our early observations,1 as well as those of McDermott and his associates,2 brought out that relapses of typhoid were common in treated patients. In order to eliminate such occurrences, we have prolonged the course of treatment in persons infected with Salmonella typhosa. Analysis of the results obtained in 44 patients with typhoid who received chloramphenicol therapeutically under our observation has indicated a striking relation between the duration of chemotherapy and the incidence of relapses.

Although our observations are being reported in detail

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs